睿知中国医院研究地图
候选清单

广州广州医科大学

广州市妇女儿童医疗中心

Guangzhou Women and Children's Medical Center

在本站收录的 53 种疾病中,这家医院列在其中 24 种下,依据是它牵头的研究论文,以及它作为牵头方或研究中心登记的试验。

这里展示的是公开记录中的研究活动,不是医疗水平评级。能否为某位患者提供帮助,应由医院和主治医生判断。

这家医院的官网还没有核对。

联系这家医院

广州市妇女儿童医疗中心的研究

选择一种疾病,查看背后的论文和试验。 每个方块显示 2021–2025 年牵头的论文数和每年的数量。

只包括本站收录的 53 种疾病。未列出某种疾病,表示在这些记录中这家医院没有达到该病的列出标准,不代表它不诊治该病。 哪些医院会被列出

  1. 鼻咽癌Nasopharyngeal carcinoma2 篇牵头论文
  2. 肝母细胞瘤Hepatoblastoma9 篇牵头论文
  3. 视网膜母细胞瘤Retinoblastoma3 篇牵头论文
  4. 骨肉瘤Osteosarcoma1 篇牵头论文
  5. 胃肠道间质瘤Gastrointestinal stromal tumour0 篇牵头论文
  6. 神经母细胞瘤Neuroblastoma32 篇牵头论文牵头 1 项开放试验
  7. B 细胞急性淋巴细胞白血病B-cell acute lymphoblastic leukaemia2 篇牵头论文牵头 1 项开放试验
  8. β 地中海贫血Beta thalassaemia19 篇牵头论文牵头 1 项开放试验
  9. 血友病 AHaemophilia A0 篇牵头论文
  10. 视神经脊髓炎谱系疾病Neuromyelitis optica spectrum disorder1 篇牵头论文
  11. 肝豆状核变性Wilson disease2 篇牵头论文
  12. 胆道闭锁Biliary atresia19 篇牵头论文
  13. 抗 NMDA 受体脑炎Anti-NMDA receptor encephalitis3 篇牵头论文
  14. 特发性肺纤维化Idiopathic pulmonary fibrosis1 篇牵头论文
  15. 肌萎缩侧索硬化症Amyotrophic lateral sclerosis0 篇牵头论文
  16. 庞贝病Pompe disease1 篇牵头论文
  17. 杜氏肌营养不良Duchenne muscular dystrophy2 篇牵头论文
  18. Alport 综合征Alport syndrome2 篇牵头论文
  19. IgA 肾病IgA nephropathy0 篇牵头论文
  20. 戈谢病Gaucher disease1 篇牵头论文
  21. 成骨不全症Osteogenesis imperfecta1 篇牵头论文
  22. 原发性硬化性胆管炎Primary sclerosing cholangitis0 篇牵头论文
  23. 先天性膈疝Congenital diaphragmatic hernia11 篇牵头论文
  24. 先天性巨结肠Hirschsprung disease7 篇牵头论文

未列出的收录疾病:食管鳞状细胞癌、肝细胞癌、胃癌、脊索瘤、尤文肉瘤、多发性骨髓瘤、再生障碍性贫血、噬血细胞性淋巴组织细胞增生症、非典型溶血性尿毒症综合征、血栓性血小板减少性紫癜、范可尼贫血、IgG4相关性疾病、重症肌无力、烟雾病、大动脉炎、肝包虫病、肺淋巴管平滑肌瘤病、脊髓性肌萎缩症、法布雷病、白塞病、尼曼-匹克病 C 型、原发性胆汁性胆管炎、遗传性大疱性表皮松解症、遗传性血管性水肿、家族性腺瘤性息肉病、Leber 遗传性视神经病变、Majeed 综合征、NGLY1 缺乏症、ISG15 缺乏症。

癌症

鼻咽癌

Nasopharyngeal carcinoma

2021–2025 年中国大陆作者发表的 2,375 篇鼻咽癌 PubMed 英文论文中,这家医院牵头了 2 篇,占 0.08%。

牵头论文
2
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 1120212022: 0020222023: 1120232024: 0020242025: 002025

广州有 24 家医院列在鼻咽癌下全国有 183 家医院列在鼻咽癌下

截至 2026年11月8日,ClinicalTrials.gov 上没有列出这家医院的鼻咽癌开放试验。

这些数字背后的记录
研究主题放疗技术影像与人工智能复发与转移
论文中的科室影像/核医学科

打开 PubMed 检索ClinicalTrials.gov

癌症

肝母细胞瘤

Hepatoblastoma

2021–2025 年中国大陆作者发表的 154 篇肝母细胞瘤 PubMed 英文论文中,这家医院牵头了 9 篇,占 5.8%。

牵头论文
9
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 3320212022: 1120222023: 1120232024: 1120242025: 332025

广州有 8 家医院列在肝母细胞瘤下全国有 86 家医院列在肝母细胞瘤下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的肝母细胞瘤开放试验。

这些数字背后的记录
论文中的科室儿科病理/检验科肿瘤内科
牵头的论文9
  1. Association of the YTHDF2 rs3738067 A>G variant with hepatoblastoma risk: a multicenter case-control study in Chinese children.2025BMC cancer
  2. Association of the pri-miR-34b/c rs4938723 T > C polymorphism with hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study.2025BMC medical genomics
  3. nNOS-mediated S-nitrosylation of TCOF1 regulates KRAS proteostasis to suppress hepatoblastoma progression.2025Redox biology
  4. IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway.2024Current molecular pharmacology
  5. TRMT61B rs4563180 G>C variant reduces hepatoblastoma risk: a case-control study of seven medical centers.2023Aging
  6. METTL14 gene polymorphisms influence hepatoblastoma predisposition in Chinese children: Evidences from a seven-center case-control study.2022Gene
  7. Polymorphisms in METTL3 gene and hepatoblastoma risk in Chinese children: A seven-center case-control study.2021Gene
  8. Genetic variations in nucleotide excision repair pathway genes and hepatoblastoma susceptibility.2021International journal of cancer
  9. Association between lncRNA-H19 polymorphisms and hepatoblastoma risk in an ethic Chinese population.2021Journal of cellular and molecular medicine
早期论文(2016–2020 年)5
  1. Outcomes of children with hepatoblastoma who underwent liver resection at a tertiary hospital in China: a retrospective analysis.2020BMC pediatrics
  2. Liver biopsy for hepatoblastoma: a single institution's experience.2020Pediatric surgery international
  3. YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in Chinese children: A seven-center case-control study.2020The journal of gene medicine
  4. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.2020The journal of gene medicine
  5. Microwave ablation combined with transcatheter arterial chemoembolization is effective for treating unresectable hepatoblastoma in infants and children.2018Medicine

打开 PubMed 检索ClinicalTrials.gov

癌症

视网膜母细胞瘤

Retinoblastoma

2021–2025 年中国大陆作者发表的 301 篇视网膜母细胞瘤 PubMed 英文论文中,这家医院牵头了 3 篇,占 1.0%。

牵头论文
3
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 1120212022: 1120222023: 0020232024: 0020242025: 112025

广州有 8 家医院列在视网膜母细胞瘤下全国有 176 家医院列在视网膜母细胞瘤下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的视网膜母细胞瘤开放试验。

这些数字背后的记录
论文中的科室影像/核医学科

打开 PubMed 检索ClinicalTrials.gov

癌症

骨肉瘤

Osteosarcoma

2021–2025 年中国大陆作者发表的 2,257 篇骨肉瘤 PubMed 英文论文中,这家医院牵头了 1 篇,占 0.04%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

广州有 30 家医院列在骨肉瘤下全国有 570 家医院列在骨肉瘤下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的骨肉瘤开放试验。

这些数字背后的记录
论文中的科室儿科
牵头的论文1
  1. The role of m6A modification in pediatric cancer.2022Biochimica et biophysica acta. Reviews on cancer
早期论文(2016–2020 年)2
  1. Different formins restrict localization of distinct tropomyosins on dorsal stress fibers in osteosarcoma cells.2020Cytoskeleton (Hoboken, N.J.)
  2. LDOC1 regulates Wnt5a expression and osteosarcoma cell metastasis and is correlated with the survival of osteosarcoma patients.2017Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

打开 PubMed 检索ClinicalTrials.gov

癌症

胃肠道间质瘤

Gastrointestinal stromal tumour

2021–2025 年没有牵头胃肠道间质瘤的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

广州有 12 家医院列在胃肠道间质瘤下全国有 240 家医院列在胃肠道间质瘤下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的胃肠道间质瘤开放试验。

这些数字背后的记录

打开 PubMed 检索ClinicalTrials.gov

癌症

神经母细胞瘤

Neuroblastoma

2021–2025 年中国大陆作者发表的 1,132 篇神经母细胞瘤 PubMed 英文论文中,这家医院牵头了 32 篇,占 2.8%。

牵头论文
32
2021–2025 年
牵头试验
1
任何状态,ClinicalTrials.gov
牵头的开放试验
1
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 4420212022: 4420222023: 8820232024: 1120242025: 15152025

广州有 22 家医院列在神经母细胞瘤下全国有 321 家医院列在神经母细胞瘤下

这家医院参与的开放试验 1

依据 ClinicalTrials.gov 在 2026年11月13日 的登记,包括正在招募、即将招募和邀请入组。仅在中国临床试验注册中心(ChiCTR)登记的试验不在其中。能否参加由研究团队决定。

  1. 正在招募
    Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
    分期
    未注明
    开始
    2024-05
    登记号
    NCT06574698

    年龄 1 岁 至 21 岁(登记的条件)

    牵头:广州市妇女儿童医疗中心广州

在试验总页面查看

排列:先正在招募,再即将招募和邀请入组;同类按开始时间从新到旧。不是排名。

这些数字背后的记录
论文中的科室儿科病理/检验科
牵头的论文32
  1. Association between MYCN gene polymorphisms and neuroblastoma susceptibility: a case-control study in Chinese children from Jiangsu Province.2025BMC cancer
  2. m1A methylase TRMT6 promotes neuroblastoma development by demethylating SST mRNA in an m1A/YTHDF2-dependent manner.2025British journal of cancer
  3. Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.2025Cell death & disease
  4. Associations of CCAT2 gene polymorphisms with neuroblastoma susceptibility in children from Jiangsu province.2025European journal of medical research
  5. Association of MALAT1 gene polymorphisms with neuroblastoma susceptibility in children from Jiangsu Province.2025Human genomics
  6. Genetic variants of m1A modification genes and the risk of neuroblastoma: novel insights from a Chinese case-control study.2025Human genomics
  7. YTHDF3 rs7464 A > G polymorphism increases Chinese neuroblastoma risk: A multiple-center case-control study.2025IUBMB life
  8. Association of TRDMT1 Gene Polymorphisms With Neuroblastoma Susceptibility: Insights From a Case-Control Study.2025Journal of cellular and molecular medicine
  9. EDF1 accelerates ganglioside GD3 accumulation to boost CD52-mediated CD8+ T cell dysfunction in neuroblastoma.2025Journal of experimental & clinical cancer research : CR
  10. Identification of IFI27 involvement in the progression of neuroblastoma through bioinformatics analysis and experimental assays.2025Journal of molecular histology
  11. Increased risk of neuroblastoma in Chinese children from Jiangsu province with NSUN4 gene rs10736428 A>C polymorphism.2025Journal of neurosurgery. Pediatrics
  12. The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma.2025Neuro-oncology
  13. Leptin decreases Th17/Treg ratio to facilitate neuroblastoma via inhibiting long-chain fatty acid catabolism in tumor cells.2025Oncoimmunology
  14. Neuroblastoma susceptibility and association of N7-methylguanosine modification gene polymorphisms: multi-center case-control study.2025Pediatric research
  15. RAS gene polymorphisms confer the risk of neuroblastoma in Chinese children from Jiangsu province.2025Pediatric surgery international
  16. Functional TET2 gene polymorphisms increase the risk of neuroblastoma in Chinese children.2024IUBMB life
  17. Comprehensive exploration of the involvement of cuproptosis in tumorigenesis and progression of neuroblastoma.2023BMC genomics
  18. MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children.2023Bioscience reports
  19. miR-100 rs1834306 a > G polymorphism decreases neuroblastoma risk in Chinese children.2023Cancer reports (Hoboken, N.J.)
  20. NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk.2023Gene
  21. Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.2023Journal for immunotherapy of cancer
  22. Functional polymorphisms of the TET1 gene increase the risk of neuroblastoma in Chinese children.2023Journal of cellular and molecular medicine
  23. Association between GPC2 polymorphisms and neuroblastoma risk in Chinese children.2023Journal of clinical laboratory analysis
  24. Iron overload facilitates neonatal hypoxic-ischemic brain damage via SLC7A11-mediated ferroptosis.2023Journal of neuroscience research
  25. SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.2022Cell death & disease
  26. Clinical Significance of a CD3/CD8-Based Immunoscore in Neuroblastoma Patients Using Digital Pathology.2022Frontiers in immunology
  27. circ0125803 facilitates tumor progression by sponging miR-197-5p and upregulating E2F1 in neuroblastoma.2022Pathology, research and practice
  28. Targeting RAS in neuroblastoma: Is it possible?2022Pharmacology & therapeutics
  29. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma.2021Cell death & disease
  30. FABP4 deactivates NF-κB-IL1α pathway by ubiquitinating ATPB in tumor-associated macrophages and promotes neuroblastoma progression.2021Clinical and translational medicine
  31. Curcumin induced G2/M cycle arrest in SK-N-SH neuroblastoma cells through the ROS-mediated p53 signaling pathway.2021Journal of food biochemistry
  32. hsa_circ_0013401 Accelerates the Growth and Metastasis and Prevents Apoptosis and Autophagy of Neuroblastoma Cells by Sponging miR-195 to Release PAK2.2021Oxidative medicine and cellular longevity
早期论文(2016–2020 年)29
  1. Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children.2020Cancer communications (London, England)
  2. lncRNA-uc003opf.1 rs11752942 A>G polymorphism decreases neuroblastoma risk in Chinese children.2020Cell cycle (Georgetown, Tex.)
  3. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.2020Journal of cellular and molecular medicine
  4. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: A four-center case-control study.2020The journal of gene medicine
  5. [Cervical giant neuroblastoma in an infant: a case report].2020Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
  6. Pleiotropic effect of common PHOX2B variants in Hirschsprung disease and neuroblastoma.2019Aging
  7. Nodal increases the malignancy of childhood neuroblastoma cells via regulation of Zeb1.2019BioFactors (Oxford, England)
  8. Targeting β3-adrenergic receptor signaling inhibits neuroblastoma cell growth via suppressing the mTOR pathway.2019Biochemical and biophysical research communications
  9. Associations between H19 polymorphisms and neuroblastoma risk in Chinese children.2019Bioscience reports
  10. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.2019Journal of experimental & clinical cancer research : CR
  11. Impact of extent of resection on survival in high-risk neuroblastoma: A systematic review and meta-analysis.2019Journal of pediatric surgery
  12. Heat shock protein 70 as a supplementary receptor facilitates enterovirus 71 infections in vitro.2019Microbial pathogenesis
  13. APEX1 Polymorphisms and Neuroblastoma Risk in Chinese Children: A Three-Center Case-Control Study.2019Oxidative medicine and cellular longevity
  14. Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children.2018Aging
  15. The rs2147578 C > G polymorphism in the Inc-LAMC2-1:1 gene is associated with increased neuroblastoma risk in the Henan children.2018BMC cancer
  16. Lack of associations between AURKA gene polymorphisms and neuroblastoma susceptibility in Chinese children.2018Bioscience reports
  17. LINC00673 rs11655237 C>T confers neuroblastoma susceptibility in Chinese population.2018Bioscience reports
  18. HOTAIR gene polymorphisms contribute to increased neuroblastoma susceptibility in Chinese children.2018Cancer
  19. Functional Polymorphisms at ERCC1/XPF Genes Confer Neuroblastoma Risk in Chinese Children.2018EBioMedicine
  20. RSRC1 and CPZ gene polymorphisms with neuroblastoma susceptibility in Chinese children.2018Gene
  21. MiR-181a/b induce the growth, invasion, and metastasis of neuroblastoma cells through targeting ABI1.2018Molecular carcinogenesis
  22. The TP53 gene rs1042522 C>G polymorphism and neuroblastoma risk in Chinese children.2017Aging
  23. Recombinant heat shock protein 78 enhances enterovirus 71 propagation in Vero cells and is induced in SK-N-SH cells during the infection.2017Archives of virology
  24. Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed.2017Pediatric surgery international
  25. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.2016International journal of medical sciences
  26. Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children.2016Journal of cellular and molecular medicine
  27. Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population.2016Journal of cellular and molecular medicine
  28. LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.2016Oncotarget
  29. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.2016Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
它在 ClinicalTrials.gov 上的全部试验(任何状态)1
  1. Adding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma正在招募NCT06574698牵头方2024-05 启动

打开 PubMed 检索ClinicalTrials.gov

血液疾病

B 细胞急性淋巴细胞白血病

B-cell acute lymphoblastic leukaemia

2021–2025 年中国大陆作者发表的 225 篇B 细胞急性淋巴细胞白血病 PubMed 英文论文中,这家医院牵头了 2 篇,占 0.9%。

牵头论文
2
2021–2025 年
牵头试验
1
任何状态,ClinicalTrials.gov
牵头的开放试验
1
正在或即将招募
作为研究中心的开放试验
4
由其他机构牵头
每年牵头的论文数
2021: 2220212022: 0020222023: 0020232024: 0020242025: 002025

广州有 8 家医院列在B 细胞急性淋巴细胞白血病下全国有 88 家医院列在B 细胞急性淋巴细胞白血病下

这家医院参与的开放试验 5

依据 ClinicalTrials.gov 在 2026年11月8日 的登记,包括正在招募、即将招募和邀请入组。仅在中国临床试验注册中心(ChiCTR)登记的试验不在其中。能否参加由研究团队决定。

  1. 正在招募
    CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
    分期
    I期
    开始
    2024-10
    登记号
    NCT06752785

    年龄 1 岁 至 18 岁(登记的条件)

    牵头:广州市妇女儿童医疗中心广州

  2. 正在招募
    Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
    分期
    II/III期
    开始
    2025-01
    登记号
    NCT06764238

    年龄 1 个月 至 18 岁(登记的条件)

    牵头:中国医学科学院血液病医院(血液学研究所);另有 24 家列出的医院为研究中心上海、南京、南宁、南昌、合肥、天津、广州、成都、武汉、济南、深圳、福州、苏州、西安、贵阳、重庆、长沙、青岛

  3. 正在招募
    Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
    分期
    II/III期
    开始
    2025-03
    登记号
    NCT06882057

    年龄 1 岁 至 18 岁(登记的条件)

    牵头:中国医学科学院血液病医院(血液学研究所);另有 23 家列出的医院为研究中心上海、南京、南宁、南昌、合肥、天津、广州、成都、武汉、济南、福州、苏州、西安、贵阳、重庆、长沙、青岛

  4. 正在招募
    Newly-diagnosed Pediatric Ph-positive B-ALL Protocol
    分期
    III期
    开始
    2025-03
    登记号
    NCT07152041

    年龄 1 个月 至 18 岁(登记的条件)

    牵头:中国医学科学院血液病医院(血液学研究所);另有 20 家列出的医院为研究中心上海、南京、南昌、天津、广州、成都、武汉、济南、深圳、福州、苏州、贵阳、重庆、长沙、青岛

  5. 正在招募
    A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)
    分期
    I/II期
    开始
    2023-02
    登记号
    NCT05667506

    年龄 3 岁 至 18 岁(登记的条件)

    牵头方不是列出的医院;另有 9 家列出的医院为研究中心南京、南昌、合肥、天津、广州、徐州、武汉、重庆

在试验总页面查看

排列:先正在招募,再即将招募和邀请入组;同类按开始时间从新到旧。不是排名。

这些数字背后的记录
研究主题微小残留病与复发儿童
论文中的科室肿瘤内科

打开 PubMed 检索ClinicalTrials.gov

血液疾病

β 地中海贫血

Beta thalassaemia

2021–2025 年中国大陆作者发表的 312 篇β 地中海贫血 PubMed 英文论文中,这家医院牵头了 19 篇,占 6.1%。

牵头论文
19
2021–2025 年
牵头试验
1
任何状态,ClinicalTrials.gov
牵头的开放试验
1
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 4420212022: 7720222023: 4420232024: 1120242025: 332025

广州有 18 家医院列在β 地中海贫血下全国有 133 家医院列在β 地中海贫血下

这家医院参与的开放试验 1

依据 ClinicalTrials.gov 在 2026年11月13日 的登记,包括正在招募、即将招募和邀请入组。仅在中国临床试验注册中心(ChiCTR)登记的试验不在其中。能否参加由研究团队决定。

  1. 正在招募
    Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia
    分期
    不分期
    开始
    2024-10
    登记号
    NCT06734520

    年龄 7 岁 至 10 岁(登记的条件)

    牵头:广州市妇女儿童医疗中心广州

在试验总页面查看

排列:先正在招募,再即将招募和邀请入组;同类按开始时间从新到旧。不是排名。

这些数字背后的记录
牵头的论文19
  1. Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation.2025European journal of clinical pharmacology
  2. Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern China.2025Hemoglobin
  3. Risk-Stratified Pretransplant Immunosuppressive Strategy Improves Outcomes of Unrelated Cord Blood Transplantation in Pediatric β-Thalassemia Major.2025Transplantation and cellular therapy
  4. A 6-Year Follow-up of a Chinese Child with Homozygous β0-Thalaasemia and a Heterozygous KLF1 Mutation.2024Hemoglobin
  5. Application of real-time PCR-based multicolor melting curve with automatic analysis system in pregestational and prenatal thalassemia diagnoses.2023Annals of human genetics
  6. High accuracy of single-molecule real-time sequencing in detecting a rare α-globin fusion gene in carrier screening population.2023Annals of human genetics
  7. β-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.2023Hemoglobin
  8. Gut microbiota trajectory in β-thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation.2023Transplant infectious disease : an official journal of the Transplantation Society
  9. Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia.2022Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
  10. Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing.2022Gene
  11. Identification of a Novel Mutation in the 3' Untranslated Region of the β-Globin Gene (HBB:c.*132C>G) in a Chinese Family.2022Hemoglobin
  12. β-Thalassemia Intermedia Caused by the β-Globin Gene 3' Untranslated Region: Another Case Report.2022Hemoglobin
  13. Dominantly Inherited β-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the β-Globin Gene: Hb Xiangyang (HBB: c.393delT).2022Hemoglobin
  14. Dysregulated Serum Cytokine Production in Pediatric Patients with β-Thalassemia Major.2022Hemoglobin
  15. Using affected embryos to establish linkage phase in preimplantation genetic testing for thalassemia.2022Reproductive biology and endocrinology : RB&E
  16. Improved Non-Invasive Preimplantation Genetic Testing for Beta-Thalassemia Using Spent Embryo Culture Medium Containing Blastocoelic Fluid.2021Frontiers in endocrinology
  17. Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping.2021Genome medicine
  18. Dominant β-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.2021Hemoglobin
  19. Hb Lepore-Hong Kong: First Report of a Novel δ/β-Globin Gene Fusion in a Chinese Family.2021Hemoglobin
中文论文(未计入)1
  1. [Molecular Epidemiological Characteristics and Differential Diagnosis of Common δβ-Thalassemia/HPFH].2022Zhongguo shi yan xue ye xue za zhi
早期论文(2016–2020 年)24
  1. Molecular epidemiology and hematologic characterization of δβ-thalassemia and hereditary persistence of fetal hemoglobin in 125,661 families of greater Guangzhou area, the metropolis of southern China.2020BMC medical genetics
  2. The Trend in Timing of Prenatal Diagnosis for Thalassemia at a Chinese Tertiary Obstetric Center.2020Hemoglobin
  3. Hematological Characteristics of β-Globin Gene Mutation -50 (G>A) (HBB: c.-100G>A) Carriers in Mainland China.2020Hemoglobin
  4. [Research advances in transplantation for thalassemia major].2020Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
  5. A β-Thalassemia Trait with Two Mutations in Cis in a Chinese Family.2019Hemoglobin
  6. Coinheritance of Hb City of Hope (HBB: c.208G>A) and β-Thalassemia: Compromising the Molecular Diagnosis of the Codons 71/72 (+A) (HBB: c.216_217insA) Mutation by Reverse Dot-Blot Hybridization.2019Hemoglobin
  7. A Krüppel-Like Factor 1 Gene Mutation Ameliorates the Severity of β-Thalassemia: A Case Report.2019Hemoglobin
  8. Regulatory Single Nucleotide Polymorphism rs368698783 (G>A): a Genetic Modifier of Hb F Production Only under Erythropoietic Stress Characteristic for β-Globin Chain Deficiency?2019Hemoglobin
  9. α-Haemoglobin pool measurement: a useful biomarker for evaluation of β-thalassaemia intermedia?2018British journal of haematology
  10. Results of Coexistence of β-Thalassemia Minor in Hb H Disease Patients.2018Hemoglobin
  11. Analysis of the Genotypes in a Chinese Population with Increased Hb A2 and Low Hematological Indices.2018Hemoglobin
  12. δ-Thalassemia with Complete Absence of Hb A2 in a Chinese Family.2018Hemoglobin
  13. A KLF1 gene mutation causes β-thalassemia minor in a Chinese family.2018International journal of laboratory hematology
  14. Invasive prenatal diagnosis of fetal thalassemia.2017Best practice & research. Clinical obstetrics & gynaecology
  15. Hb Hornchurch [β43(CD2)Glu→Lys; HBB: c.130G>A] Compromises the Molecular Diagnosis of β-Thalassemia in a Chinese Family.2017Hemoglobin
  16. Hb A2-Tianhe (HBD: c.323G>A): First Report in a Chinese Family with Normal Hb A2-β-Thalassemia Trait.2017Hemoglobin
  17. First Report of the Rare IVS-II-705 (T>G) β-Thalassemia Mutation in a Chinese Family.2017Hemoglobin
  18. A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the β-Globin Gene Leads to β-Thalassemia.2017Hemoglobin
  19. Combination of Hb Heze [β144(HC1)Lys→Arg; HBB: c.434A>G] and β0-Thalassemia in a Chinese Patient with β-Thalassemia Intermedia.2017Hemoglobin
  20. Characterization of a novel β-globin gene cluster deletion causing (A γδβ)0 -thalassemia by next-generation sequencing.2017International journal of laboratory hematology
  21. Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemia: A pediatric case report.2017Medicine
  22. A New δ-Globin Gene Variant: Hb A2-Fengshun [δ121(GH4)Glu→Lys (HBD: c.364G > A)].2016Hemoglobin
  23. Consequences of Delayed Prenatal Diagnosis of β-Thalassemia in Mainland China.2016Hemoglobin
  24. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.2016Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
它在 ClinicalTrials.gov 上的全部试验(任何状态)2
  1. Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia正在招募NCT06734520牵头方不分期2024-10 启动
  2. A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia已终止NCT04925206研究中心I期2021-08 启动

打开 PubMed 检索ClinicalTrials.gov

血液疾病

血友病 A

Haemophilia A

2021–2025 年没有牵头血友病 A的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

广州有 6 家医院列在血友病 A下全国有 132 家医院列在血友病 A下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的血友病 A开放试验。

这些数字背后的记录
早期论文(2016–2020 年)2
  1. The impact of GPIbα on platelet-targeted FVIII gene therapy in hemophilia A mice with pre-existing anti-FVIII immunity.2019Journal of thrombosis and haemostasis : JTH
  2. [Research Progress on Genetic Factors and Hemophilia A Clotting Factor Inhibitor-Review].2017Zhongguo shi yan xue ye xue za zhi
它在 ClinicalTrials.gov 上的全部试验(任何状态)2
  1. Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A即将招募NCT06136507研究中心III期2026-12 启动
  2. Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products已完成NCT06738485研究中心III期2025-01 启动

打开 PubMed 检索ClinicalTrials.gov

其他疾病

视神经脊髓炎谱系疾病

Neuromyelitis optica spectrum disorder

2021–2025 年中国大陆作者发表的 485 篇视神经脊髓炎谱系疾病 PubMed 英文论文中,这家医院牵头了 1 篇,占 0.2%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
1
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

广州有 9 家医院列在视神经脊髓炎谱系疾病下全国有 67 家医院列在视神经脊髓炎谱系疾病下

这家医院参与的开放试验 1

依据 ClinicalTrials.gov 在 2026年11月8日 的登记,包括正在招募、即将招募和邀请入组。仅在中国临床试验注册中心(ChiCTR)登记的试验不在其中。能否参加由研究团队决定。

  1. 正在招募
    A Study to Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, and Pharmacodynamics of Satralizumab in Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
    分期
    III期
    开始
    2026-05
    登记号
    NCT05199688

    年龄 2 岁 至 11 岁(登记的条件)

    牵头方不是列出的医院;另有 1 家列出的医院为研究中心广州

在试验总页面查看

排列:先正在招募,再即将招募和邀请入组;同类按开始时间从新到旧。不是排名。

这些数字背后的记录
研究主题生物制剂急性发作治疗抗体与诊断
论文中的科室神经内科

打开 PubMed 检索ClinicalTrials.gov

其他疾病

肝豆状核变性

Wilson disease

2021–2025 年中国大陆作者发表的 201 篇肝豆状核变性 PubMed 英文论文中,这家医院牵头了 2 篇,占 1.0%。

牵头论文
2
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 1120222023: 0020232024: 1120242025: 002025

广州有 5 家医院列在肝豆状核变性下全国有 28 家医院列在肝豆状核变性下

截至 2026年11月8日,ClinicalTrials.gov 上没有列出这家医院的肝豆状核变性开放试验。

这些数字背后的记录
研究主题遗传学(ATP7B)诊断与铜代谢检测儿童
牵头的论文2
  1. Clinical characteristics and prognosis of early diagnosed Wilson's disease: A large cohort study.2024Liver international : official journal of the International Association for the Study of the Liver
  2. Assessment of the diagnostic value of serum ceruloplasmin for Wilson's disease in children.2022BMC gastroenterology免费全文
中文论文(未计入)1
  1. [Phenotypes and ATP7B gene variants in 316 children with Wilson disease].2022Zhonghua er ke za zhi = Chinese journal of pediatrics

打开 PubMed 检索ClinicalTrials.gov

其他疾病

胆道闭锁

Biliary atresia

2021–2025 年中国大陆作者发表的 214 篇胆道闭锁 PubMed 英文论文中,这家医院牵头了 19 篇,占 8.9%。

牵头论文
19
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 2220212022: 5520222023: 3320232024: 4420242025: 442025

广州有 2 家医院列在胆道闭锁下全国有 31 家医院列在胆道闭锁下

截至 2026年11月8日,ClinicalTrials.gov 上没有列出这家医院的胆道闭锁开放试验。

这些数字背后的记录
研究主题筛查与诊断发病机制
论文中的科室儿科影像/核医学科
牵头的论文19
  1. A dysregulated hepcidin-iron axis impairs antiviral immunity and induces lethal liver pathology in neonates.2026Immunity
  2. Dual Functions and Therapeutic Potential of FZD6 in Biliary Atresia.2025Digestive diseases and sciences
  3. Identification of Biliary Atresia in Infantile Cholestasis: Integrating Radiomics With MRCP for Unobservable Extrahepatic Biliary Systems.2025Journal of computer assisted tomography
  4. Early differential diagnosis of cystic biliary atresia and choledochal cyst in the fetus: A multicenter retrospective study.2025Journal of hepato-biliary-pancreatic sciences
  5. Comprehensive images and serum biomarkers for biliary atresia and other cholestasis in pediatrics.2025Scientific data免费全文
  6. Alterations of gut microbiota in infants with biliary atresia identified by 16S rRNA-sequencing.2024BMC pediatrics免费全文
  7. MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia.2024Clinical immunology (Orlando, Fla.)
  8. Key postnatal magnetic resonance characteristics for differentiating cystic biliary atresia from choledochal cyst.2024European radiology
  9. Proteomics Defines Plasma Biomarkers for the Early Diagnosis of Biliary Atresia.2024Journal of proteome research免费全文
  10. MiR-100 rs1834306 A>G Increases Biliary Atresia Risk in Southern Han Chinese Children.2023BioMed research international免费全文
  11. A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia.2023Journal of visualized experiments : JoVE
  12. The association of immune-related genes and the potential role of IL10 with biliary atresia.2023Pediatric research
  13. Latest diagnostic performance of different ultrasonic features for biliary atresia.2022Acta radiologica (Stockholm, Sweden : 1987)
  14. A model incorporating serum C3 complement levels may be useful for diagnosing biliary atresia in infants.2022Gastroenterologia y hepatologia
  15. Accuracy of Magnetic Resonance Imaging in Prenatal Diagnosis of Choledochal Cysts: A Single-Center Retrospective Analysis.2022International journal of clinical practice免费全文
  16. Peripheral blood CD177+ cells as an early diagnostic marker for biliary atresia: A prospective multicentre study in pediatric patients with cholestasis.2022Journal of hepatology
  17. CD177+ cells produce neutrophil extracellular traps that promote biliary atresia.2022Journal of hepatology
  18. Association of miRNA-492 rs2289030 G>C and miRNA-938 rs2505901 T>C Gene Polymorphisms with Biliary Atresia Susceptibility.2021Biomedical and environmental sciences : BES
  19. Down-regulation of STAT3 enhanced chemokine expression and neutrophil recruitment in biliary atresia.2021Clinical science (London, England : 1979)免费全文
它在 ClinicalTrials.gov 上的全部试验(任何状态)4
  1. Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy已终止NCT06121375研究中心II/III期2024-09 启动
  2. An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia进行中,不再招募NCT05426733研究中心III期2022-07 启动
  3. Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai已完成NCT04524390研究中心II期2021-07 启动
  4. Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)已完成NCT04336722研究中心III期2020-07 启动
PubMed 以外找到的论文(未计入)4
  1. A Novel Real-Time Deep Learning Screening for Prenatal and Neonatal Biliary Atresia Diagnosis for Ghost Gallbladders: Better Interpretation and More Novice-Friendly2025SSRN Electronic Journal预印本
  2. Folic acid prevents interferon-induced iron accumulation and ferroptosis and improves liver health in children with biliary atresia2023medRxiv预印本
  3. JoVE Video Dataset2023未列出期刊数据集
  4. A model incorporating serum C3 complement levels may be useful for diagnosing biliary atresia in infants2022Gastroenterología y Hepatología (English Edition)论文

打开 PubMed 检索ClinicalTrials.gov

其他疾病

抗 NMDA 受体脑炎

Anti-NMDA receptor encephalitis

2021–2025 年中国大陆作者发表的 264 篇抗 NMDA 受体脑炎 PubMed 英文论文中,这家医院牵头了 3 篇,占 1.1%。

牵头论文
3
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 1120212022: 0020222023: 0020232024: 1120242025: 112025

广州有 12 家医院列在抗 NMDA 受体脑炎下全国有 124 家医院列在抗 NMDA 受体脑炎下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的抗 NMDA 受体脑炎开放试验。

这些数字背后的记录
论文中的科室神经内科

打开 PubMed 检索ClinicalTrials.gov

其他疾病

特发性肺纤维化

Idiopathic pulmonary fibrosis

2021–2025 年中国大陆作者发表的 989 篇特发性肺纤维化 PubMed 英文论文中,这家医院牵头了 1 篇,占 0.1%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 0020222023: 1120232024: 0020242025: 002025

广州有 20 家医院列在特发性肺纤维化下全国有 288 家医院列在特发性肺纤维化下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的特发性肺纤维化开放试验。

这些数字背后的记录
论文中的科室儿科

打开 PubMed 检索ClinicalTrials.gov

其他疾病

肌萎缩侧索硬化症

Amyotrophic lateral sclerosis

2021–2025 年没有牵头肌萎缩侧索硬化症的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

广州有 13 家医院列在肌萎缩侧索硬化症下全国有 182 家医院列在肌萎缩侧索硬化症下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的肌萎缩侧索硬化症开放试验。

这些数字背后的记录

打开 PubMed 检索ClinicalTrials.gov

其他疾病

庞贝病

Pompe disease

2021–2025 年中国大陆作者发表的 30 篇庞贝病 PubMed 英文论文中,这家医院牵头了 1 篇,占 3.3%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 1120222023: 0020232024: 0020242025: 002025

广州有 2 家医院列在庞贝病下全国有 30 家医院列在庞贝病下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的庞贝病开放试验。

这些数字背后的记录
牵头的论文1
  1. Retrospective analysis of prenatal ultrasound of children with Pompe disease.2022Taiwanese journal of obstetrics & gynecology
中文论文(未计入)1
  1. [GAA gene variants and genotype-phenotype correlations in patients with glycogen storage disease type Ⅱ].2021Zhonghua er ke za zhi = Chinese journal of pediatrics
早期论文(2016–2020 年)1
  1. Clinical and GAA gene mutation analysis in 21 Chinese patients with classic infantile pompe disease.2020European journal of medical genetics

打开 PubMed 检索ClinicalTrials.gov

其他疾病

杜氏肌营养不良

Duchenne muscular dystrophy

2021–2025 年中国大陆作者发表的 213 篇杜氏肌营养不良 PubMed 英文论文中,这家医院牵头了 2 篇,占 0.9%。

牵头论文
2
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 2220222023: 0020232024: 0020242025: 002025

广州有 7 家医院列在杜氏肌营养不良下全国有 111 家医院列在杜氏肌营养不良下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的杜氏肌营养不良开放试验。

这些数字背后的记录

打开 PubMed 检索ClinicalTrials.gov

其他疾病

Alport 综合征

Alport syndrome

2021–2025 年中国大陆作者发表的 58 篇Alport 综合征 PubMed 英文论文中,这家医院牵头了 2 篇,占 3.5%。

牵头论文
2
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 1120212022: 0020222023: 0020232024: 0020242025: 112025

广州有 5 家医院列在Alport 综合征下全国有 60 家医院列在Alport 综合征下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的Alport 综合征开放试验。

这些数字背后的记录
论文中的科室肾内科

打开 PubMed 检索ClinicalTrials.gov

其他疾病

IgA 肾病

IgA nephropathy

2021–2025 年没有牵头IgA 肾病的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

广州有 16 家医院列在IgA 肾病下全国有 300 家医院列在IgA 肾病下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的IgA 肾病开放试验。

这些数字背后的记录

打开 PubMed 检索ClinicalTrials.gov

其他疾病

戈谢病

Gaucher disease

2021–2025 年中国大陆作者发表的 30 篇戈谢病 PubMed 英文论文中,这家医院牵头了 1 篇,占 3.3%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 1120212022: 0020222023: 0020232024: 0020242025: 002025

广州有 4 家医院列在戈谢病下全国有 40 家医院列在戈谢病下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的戈谢病开放试验。

这些数字背后的记录
牵头的论文1
  1. Detection of glucosylsphingosine in dried blood spots for diagnosis of Gaucher disease by LC-MS/MS.2021Clinical biochemistry
早期论文(2016–2020 年)2
  1. High risk screening for Gaucher disease in patients with splenomegaly and/or thrombocytopenia in China: 55 cases identified.2020Clinica chimica acta; international journal of clinical chemistry
  2. Clinical and molecular characteristics of patients with Gaucher disease in Southern China.2018Blood cells, molecules & diseases
它在 ClinicalTrials.gov 上的全部试验(任何状态)1
  1. A Study of Velaglucerase Alfa (VPRIV) in Chinese Children, Teenagers, and Adults With Type 1 Gaucher Disease已完成NCT05529992研究中心III期2023-01 启动

打开 PubMed 检索ClinicalTrials.gov

其他疾病

成骨不全症

Osteogenesis imperfecta

2021–2025 年中国大陆作者发表的 99 篇成骨不全症 PubMed 英文论文中,这家医院牵头了 1 篇,占 1.0%。

牵头论文
1
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 0020222023: 0020232024: 0020242025: 112025

广州有 2 家医院列在成骨不全症下全国有 58 家医院列在成骨不全症下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的成骨不全症开放试验。

这些数字背后的记录
论文中的科室儿科

打开 PubMed 检索ClinicalTrials.gov

其他疾病

原发性硬化性胆管炎

Primary sclerosing cholangitis

2021–2025 年没有牵头原发性硬化性胆管炎的 PubMed 英文论文。下方可查看与这家医院关联的研究记录。

牵头论文
0
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头

广州有 8 家医院列在原发性硬化性胆管炎下全国有 89 家医院列在原发性硬化性胆管炎下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的原发性硬化性胆管炎开放试验。

这些数字背后的记录
早期论文(2016–2020 年)1
  1. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.2018World journal of gastroenterology

打开 PubMed 检索ClinicalTrials.gov

其他疾病

先天性膈疝

Congenital diaphragmatic hernia

2021–2025 年中国大陆作者发表的 60 篇先天性膈疝 PubMed 英文论文中,这家医院牵头了 11 篇,占 18.3%。

牵头论文
11
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 0020212022: 1120222023: 2220232024: 5520242025: 332025

广州有 4 家医院列在先天性膈疝下全国有 44 家医院列在先天性膈疝下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的先天性膈疝开放试验。

这些数字背后的记录
论文中的科室影像/核医学科儿科
牵头的论文11
  1. Genetic burden and multidimensional predictors in prenatal diagnosis of fetal congenital diaphragmatic hernia.2025Human genetics
  2. Predictive Value of Esophageal Deviation Index for Clinical Outcomes of Patients With Left-Sided Congenital Diaphragmatic Hernia.2025Journal of pediatric surgery
  3. The timing of surgery for congenital diaphragmatic hernia in infants receiving extracorporeal membrane oxygenation: a meta-analysis.2025Pediatric surgery international
  4. The Timing of Surgery for Congenital Diaphragmatic Hernia in Infants, on or after Weaning from Extracorporeal Membrane Oxygenation: A Meta-Analysis.2024European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
  5. Prenatal MRI assessment of mediastinal shift angle as a feasible and effective risk stratification tool in isolated right-sided congenital diaphragmatic hernia.2024European radiology
  6. Relative Mediastinal Displacement Index (RMDI): A Prenatal MRI Indicator of Adverse Events in Fetuses With Isolated Left Congenital Diaphragmatic Hernia.2024Journal of magnetic resonance imaging : JMRI
  7. Extracorporeal membrane oxygenation for congenital diaphragmatic hernia: how to begin?2024Minerva pediatrics
  8. Mechanical ventilation in special populations.2024Seminars in perinatology
  9. First-trimester prenatal diagnosis of Coffin-Siris syndrome-related congenital diaphragmatic hernia: The role of exome sequencing in determining genetic etiology.2023Congenital anomalies
  10. Mediastinal shift angle (MSA) measurement with MRI: a simple and effective tool for prenatal risk stratification in fetuses with congenital diaphragmatic hernia.2023European radiology
  11. Prenatal diagnosis of Coffin-Siris syndrome: What are the fetal features?2022Prenatal diagnosis
早期论文(2016–2020 年)4
  1. Simple and safe thoracoscopic repair of neonatal congenital diaphragmatic hernia by a new modified knot-tying technique.2019Hernia : the journal of hernias and abdominal wall surgery
  2. Standardized Indications to Assist in the Safe Thoracoscopic Repair of Congenital Diaphragmatic Hernia in Neonates.2016Journal of laparoendoscopic & advanced surgical techniques. Part A
  3. Decreased expression of miR-33 in fetal lungs of nitrofen-induced congenital diaphragmatic hernia rat model.2016Journal of pediatric surgery
  4. An unusual cause of shortness of breath in a young boy.2016Thorax

打开 PubMed 检索ClinicalTrials.gov

其他疾病

先天性巨结肠

Hirschsprung disease

2021–2025 年中国大陆作者发表的 161 篇先天性巨结肠 PubMed 英文论文中,这家医院牵头了 7 篇,占 4.3%。

牵头论文
7
2021–2025 年
牵头试验
0
任何状态,ClinicalTrials.gov
牵头的开放试验
0
正在或即将招募
作为研究中心的开放试验
0
由其他机构牵头
每年牵头的论文数
2021: 3320212022: 0020222023: 1120232024: 1120242025: 222025

广州有 8 家医院列在先天性巨结肠下全国有 76 家医院列在先天性巨结肠下

截至 2026年11月13日,ClinicalTrials.gov 上没有列出这家医院的先天性巨结肠开放试验。

这些数字背后的记录
论文中的科室儿科
牵头的论文7
  1. Refining the Sox10Dom/+ mouse model: A new breeding strategy with relevance to Hirschsprung disease genetics.2025Animal models and experimental medicine
  2. Suppression of SRC protein kinase activity alleviates the severity of aganglionosis by impairing CAV1/FLNA expression.2025Science progress
  3. Virus-Triggered Autoimmunity Was Associated With Hirschsprung's Disease Through Activation of Innate Immunity.2024Journal of immunology research
  4. Establishment and identification of an animal model of Hirschsprung disease in suckling mice.2023Pediatric research
  5. Correlation analysis of IL-11 polymorphisms and Hirschsprung disease subtype susceptibility in Southern Chinese Children.2021BMC medical genomics
  6. Associations of CYP2B6 genetic polymorphisms with Hirschsprung's disease in a southern Chinese population.2021Journal of clinical laboratory analysis
  7. Associations between common genetic variants in microRNAs and Hirschsprung disease susceptibility in Southern Chinese children.2021The journal of gene medicine
早期论文(2016–2020 年)14
  1. Long-term outcomes and quality of life of patients with Hirschsprung disease: a systematic review and meta-analysis.2020BMC gastroenterology
  2. Significant Association of rs2147555 Genetic Polymorphism in the EDNRB Gene with Hirschsprung Disease in Southern Chinese Children.2020BioMed research international
  3. miR-618 rs2682818 C>A polymorphism decreases Hirschsprung disease risk in Chinese children.2020Bioscience reports
  4. Parental Self-efficacy and Health-related Outcomes Among Children with Hirschsprung Disease: A Cross-sectional Study.2020Journal of pediatric nursing
  5. Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children.2020The Journal of international medical research
  6. Pleiotropic effect of common PHOX2B variants in Hirschsprung disease and neuroblastoma.2019Aging
  7. Associations of SLC6A20 genetic polymorphisms with Hirschsprung's disease in a Southern Chinese population.2019Bioscience reports
  8. Parental self-efficacy in managing the home care of children with Hirschsprung's disease or anorectal malformation: Development and validation of a new measure.2019Journal of psychosomatic research
  9. Association of VAMP5 and MCC genetic polymorphisms with increased risk of Hirschsprung disease susceptibility in Southern Chinese children.2018Aging
  10. Association between DSCAM polymorphisms and non-syndromic Hirschsprung disease in Chinese population.2018BMC medical genetics
  11. Association of NRG1 and AUTS2 genetic polymorphisms with Hirschsprung disease in a South Chinese population.2018Journal of cellular and molecular medicine
  12. Gene expression profiling coupled with Connectivity Map database mining reveals potential therapeutic drugs for Hirschsprung disease.2018Journal of pediatric surgery
  13. Establishment of an induced pluripotent stem cell model of Hirschsrpung disease, a congenital condition of the enteric nervous system, from a patient carrying a novel RET mutation.2018Neuroreport
  14. Large-scale replication study identified multiple independent SNPs in RET synergistically associated with Hirschsprung disease in Southern Chinese population.2017Aging

打开 PubMed 检索ClinicalTrials.gov

联系这家医院

出示给工作人员或司机的院名卡

广州市妇女儿童医疗中心

Guangzhou Women and Children's Medical Center

广州

大医院往往有多个院区,出发前请先向医院确认院区。

中英对照的咨询信

填写方括号中的内容后,通过医院国际医疗部或官网上的联系方式发送。在这里输入的内容不会离开您的设备。

医院通常需要的资料

  • 主治医生近期的病情总结或信件
  • 病理报告
  • 影像检查(CT、MRI、PET)及报告,尽量附影像文件
  • 已接受的治疗及时间
  • 目前用药

下一步建议

与主治医生沟通可将本页分享给主治医生,一同评估该团队的研究方向是否相关。
确认团队现状论文发表通常滞后数月,医生也可能调动。请在医院官网查询相关科室。
直接联系医院请通过医院官方公布的渠道联系。医院不向我们支付任何费用;是否接诊由医院决定。

这些数字从哪里来

论文

2021–2025 年 PubMed 英文论文中,第一作者或最后作者的第一单位是这家医院的论文。 定义

试验

ClinicalTrials.gov 上列出这家医院为牵头方或研究中心的记录,截至 2026年11月8日。

编号与其他名称

ROR
Affiliated Guangzhou Women and Children's Hospital; Affiliated Guangzhou Women and Children's Medical Center; Guangzhou Women and Children's Medical Center Liuzhou Hospital; Guangzhou Women and Children's Medical Centre; Guangzhou Women and Children Medical Center; Guangzhou Women and Children's Hospital; Liuzhou Hospital of Guangzhou Women and Children's Medical Center

提出更正下载数据